Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders

Tenapanor (RDX5791, AZD1722), a first‐in‐class small molecule with minimal systemic availability, is an inhibitor of the sodium/hydrogen exchanger isoform 3. Tenapanor acts locally in the gut, where it reduces absorption of sodium and phosphate. It is being studied in patients with chronic kidney di...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Susanne, Leonsson‐Zachrisson, Maria, Knutsson, Mikael, Spencer, Andrew G., Labonté, Eric D., Deshpande, Desiree, Kohler, Jill, Kozuka, Kenji, Charmot, Dominique, Rosenbaum, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599948/
https://www.ncbi.nlm.nih.gov/pubmed/27654985
http://dx.doi.org/10.1002/cpdd.307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599948/
https://www.ncbi.nlm.nih.gov/pubmed/27654985
http://dx.doi.org/10.1002/cpdd.307

Ejemplares similares